Vor Biopharma
VOR
VOR
61 hedge funds and large institutions have $362M invested in Vor Biopharma in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 14 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
25% less capital invested
Capital invested by funds: $481M → $362M (-$119M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
61
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$3.18M | |
| 2 | +$2.32M | |
| 3 | +$670K | |
| 4 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$470K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$346K |
Top Sellers
| 1 | -$4.05M | |
| 2 | -$3.84M | |
| 3 | -$3.74M | |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$1.34M |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$547K |